These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3114516

  • 1. [Immunohistochemical demonstration of tyrosinase 4 in normal skin and melanocytic tumors].
    Kageshita T, Ono T, Arao T, Tomita Y.
    Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):685-90. PubMed ID: 3114516
    [No Abstract] [Full Text] [Related]

  • 2. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
    Imokawa G, Mishima Y.
    Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Demonstration of tyrosinase in the adult bovine uveal tract and retinal pigment epithelium.
    Dryja TP, O'Neil-Dryja M, Pawelek JM, Albert DM.
    Invest Ophthalmol Vis Sci; 1978 Jun; 17(6):511-4. PubMed ID: 96039
    [Abstract] [Full Text] [Related]

  • 11. Immunoelectron microscopic localization of tyrosinase in the mouse melanocyte.
    Yamamoto H, Takeuchi T.
    J Histochem Cytochem; 1981 Aug; 29(8):953-8. PubMed ID: 6792273
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Mouse model of tyrosinase positive type oculocutaneous albinism (chinchilla mouse, Cch/Cch) : tyrosinase activity and ultrastructure of hair bulb melanocyte (author's transl)].
    Hori Y, Shichiro M, Mizoguchi M.
    Nihon Hifuka Gakkai Zasshi; 1980 Oct; 90(11):987-94. PubMed ID: 6780712
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Malignant melanoma--a PO-cell tumor? (author's transl)].
    Schmidt H, Stintz AR.
    Arch Geschwulstforsch; 1975 Oct; 45(2):146-52. PubMed ID: 812451
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Isolation and characterization of tyrosinase inhibitors and their differential action on melanogenic subcellular compartments in amelanotic and melanomas.
    Imokawa G, Mishima Y.
    Br J Dermatol; 1980 Dec; 103(6):625-33. PubMed ID: 6779849
    [Abstract] [Full Text] [Related]

  • 19. Electrophoretic characterization of tyrosinase in the coated vesicles of malignant melanoma.
    Mojamdar M, Imokawa G, Mishima Y.
    J Dermatol; 1979 Feb; 6(1):5-8. PubMed ID: 110860
    [No Abstract] [Full Text] [Related]

  • 20. Monoclonal antibody MAT-1 against human tyrosinase can detect melanogenic cells on formalin-fixed paraffin-embedded sections.
    Sato N, Suzuki S, Takimoto H, Masui S, Shibata K, Nakano H, Tomita Y.
    Pigment Cell Res; 1996 Apr; 9(2):72-6. PubMed ID: 8857669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.